Literature DB >> 22626465

Astaxanthin attenuates the UVB-induced secretion of prostaglandin E2 and interleukin-8 in human keratinocytes by interrupting MSK1 phosphorylation in a ROS depletion-independent manner.

Shuko Terazawa1, Hiroaki Nakajima, Mori Shingo, Takao Niwano, Genji Imokawa.   

Abstract

To elucidate the effects of redox balance regulation on cutaneous inflammation, we used the potent antioxidant astaxanthin (AX) to assess its effect on the UVB-induced secretion of PGE(2) and IL-8 in human keratinocytes and analysed its biological mechanism of action. The addition of AX (at 8 μm) to human keratinocytes even after UVB irradiation significantly down-regulated the increased secretion of PGE(2) or IL-8. Those suppressive effects were accompanied by significantly decreased expression of genes encoding COX-2 or IL-8 as well as COX-2 protein. Analysis using a specific NF-κB tanslocation inhibitor demonstrated that the UVB-stimulated secretion of PGE(2) and IL-8 was significantly abolished by its treatment prior to UVB irradiation. Western blotting of phosphorylated signalling molecules revealed that UVB irradiation (80 mJ/cm(2) ) significantly stimulated the phosphorylation of p38, ERK and JNK, which was not suppressed by treatment with AX after irradiation. In contrast, AX significantly inhibited the UVB-increased phosphorylation of mitogen- and stress-activated protein kinase (MSK)-1, NF-kBp65 or CREB even when treated postirradiation. Further, the MSK1 inhibitor H89 significantly down-regulated the increased secretion of PGE(2) and IL-8 in UVB-exposed human keratinocytes, following post-irradiation treatment. These findings suggests that AX attenuates the auto-phosphorylation of MSK1 required for its activation, which results in the decreased phosphorylation of NF-kBp65, which in turn probably leads to a deficiency of NF-kB DNA binding activity. This may be associated with the significant suppression of PGE(2) /IL-8 secretion via the down-regulated expression of COX-2 and IL-8 at the gene and/or protein levels.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22626465     DOI: 10.1111/j.1600-0625.2012.01496.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  22 in total

1.  Astaxanthin supplementation impacts the cellular HSP expression profile during passive heating.

Authors:  Chen Fleischmann; Netta Bar-Ilan; Michal Horowitz; Yaron Bruchim; Patricia Deuster; Yuval Heled
Journal:  Cell Stress Chaperones       Date:  2020-01-22       Impact factor: 3.667

2.  Asthaxanthin Improves Aerobic Exercise Recovery Without Affecting Heat Tolerance in Humans.

Authors:  Chen Fleischmann; Michal Horowitz; Ran Yanovich; Hany Raz; Yuval Heled
Journal:  Front Sports Act Living       Date:  2019-09-04

3.  Epithelial transient receptor potential ankyrin 1 (TRPA1)-dependent adrenomedullin upregulates blood flow in rat small intestine.

Authors:  Toru Kono; Atsushi Kaneko; Yuji Omiya; Katsuya Ohbuchi; Nagisa Ohno; Masahiro Yamamoto
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-12-28       Impact factor: 4.052

Review 4.  The Putative Role of Astaxanthin in Neuroinflammation Modulation: Mechanisms and Therapeutic Potential.

Authors:  Shuai Wang; Xin Qi
Journal:  Front Pharmacol       Date:  2022-06-24       Impact factor: 5.988

5.  Mycosporine-like amino acids stimulate hyaluronan secretion by up-regulating hyaluronan synthase 2 via activation of the p38/MSK1/CREB/c-Fos/AP-1 axis.

Authors:  Shuko Terazawa; Masahiko Nakano; Akio Yamamoto; Genji Imokawa
Journal:  J Biol Chem       Date:  2020-04-13       Impact factor: 5.157

Review 6.  Jakpot! New small molecules in autoimmune and inflammatory diseases.

Authors:  Kamran Ghoreschi; Massimo Gadina
Journal:  Exp Dermatol       Date:  2014-01       Impact factor: 3.960

7.  UVB protective effects of Sargassum horneri through the regulation of Nrf2 mediated antioxidant mechanism.

Authors:  Eui Jeong Han; Seo-Young Kim; Kyounghoon Lee; Ginnae Ahn; Hee-Jin Han; Hyun-Soo Kim; Kil-Nam Kim; Ilekuttige Priyan Shanura Fernando; Disanayake Mudiyanselage Dinesh Madusanka; Mawalle Kankanamge Hasitha Madhawa Dias; Sun Hee Cheong; Sang Rul Park; Young Seok Han
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

8.  Astaxanthin Pretreatment Attenuates Hepatic Ischemia Reperfusion-Induced Apoptosis and Autophagy via the ROS/MAPK Pathway in Mice.

Authors:  Jingjing Li; Fan Wang; Yujing Xia; Weiqi Dai; Kan Chen; Sainan Li; Tong Liu; Yuanyuan Zheng; Jianrong Wang; Wenxia Lu; Yuqing Zhou; Qin Yin; Jie Lu; Yingqun Zhou; Chuanyong Guo
Journal:  Mar Drugs       Date:  2015-05-27       Impact factor: 5.118

Review 9.  Astaxanthin as a Potential Neuroprotective Agent for Neurological Diseases.

Authors:  Haijian Wu; Huanjiang Niu; Anwen Shao; Cheng Wu; Brandon J Dixon; Jianmin Zhang; Shuxu Yang; Yirong Wang
Journal:  Mar Drugs       Date:  2015-09-11       Impact factor: 5.118

10.  The UVB-Stimulated Expression of Transglutaminase 1 Is Mediated Predominantly via the NFκB Signaling Pathway: New Evidence of Its Significant Attenuation through the Specific Interruption of the p38/MSK1/NFκBp65 Ser276 Axis.

Authors:  Shuko Terazawa; Shingo Mori; Hiroaki Nakajima; Michitaka Yasuda; Genji Imokawa
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.